Publication Date:
2024-03-28
Description:
This reprint entitled "Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects" contains 14 articles in total. This includes one editorial, ten research articles, and three review articles. All articles are associated with nanomedicine-based drug delivery systems for the solubility, bioavailability, and therapeutic enhancement of active drug molecules. In recent years, there has been a tremendous amount of research on nanomedicine-based drug delivery systems. This reprint has brought together prominent scientists who have explored a diverse range of applications of nanomedicine-based drug delivery systems. I believe that further clinical and toxicological studies on both animal and human models are still required to explore the complete potential and commercial exploitation of nanomedicine-based drug delivery systems. The diverse and critical perspectives within this reprint provide sufficient information on the development, characterization, and evaluation of nanomedicine-based drug delivery systems.
Keywords:
bioflavonoid
;
droplet size
;
hepatoprotective effects
;
luteolin
;
SNEDDS
;
cancer
;
smart nanocarriers
;
drug targeting
;
nanoparticles
;
stimulus for drug release
;
bioavailability
;
ciprofloxacin
;
lipid-based colloidal carriers
;
ocular delivery
;
turmeric rhizome extract
;
turmeric oil
;
curcumin
;
HepG2
;
anticancer
;
quality by design
;
quality planning
;
initial risk assessment
;
critical factors
;
thermosensitive liposomes
;
thin-film hydration method
;
dental diseases
;
essential oils
;
herb
;
natural products
;
nanotechnology
;
regulations
;
tedizolid-phosphate
;
chitosan
;
antibacterial
;
eye-irritation transcorneal-permeation
;
drug delivery
;
contraception
;
levonorgestrel
;
liposomes
;
microneedle
;
sustained-release
;
apremilast
;
psoriatic arthritis
;
pharmacokinetics studies
;
solubility
;
dissolution
;
oral bioavailability
;
functionalized fullerenes
;
fullerenols
;
antibiotics
;
gentamicin
;
antibacterial properties
;
cytotoxicity
;
skin fibroblasts
;
nanomedicine
;
tedizolid
;
antimicrobial
;
nanocrystals
;
eyeirritation
;
ocular pharmacokinetics
;
transcorneal permeation
;
quality by Design (QbD)
;
nano-pharmaceuticals
;
pharmaceutical industry
;
polyamidoamine dendrimers
;
erlotinib
;
non-small-cell lung cancer
;
n/a
;
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
;
thema EDItEUR::P Mathematics and Science::PN Chemistry
Language:
English
Format:
image/jpeg
